Lv5
1040 积分 2023-04-20 加入
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
6个月前
已完结
Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer
6个月前
已完结
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
6个月前
已完结
AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers
6个月前
已完结
Exploring the role of PI3K/AKT/mTOR inhibitors in hormone-related cancers: A focus on breast and prostate cancer
6个月前
已完结
Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
6个月前
已完结
泌尿道感染诊治循证指南（2016）
6个月前
已完结
PI3K/AKT/ mTOR signaling transduction pathway and targeted therapies in cancer
7个月前
已完结
Overall Survival with Inavolisib in PIK3CA-Mutated Advanced Breast Cancer
7个月前
已完结
RTK-Dependent Inducible Degradation of Mutant PI3Kα Drives GDC-0077 (Inavolisib) Efficacy
7个月前
已完结
皖公网安备34019202002308
